Online Only Articles

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain
Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain
Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain
Department of Internal Medicine II, University Hospital Würzburg, Germany
Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
Clinical Pharmacology Department, La Paz University Hospital, idiPAZ, UAM, Madrid, Spain
Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain
Department of Hematology, Fundación de Investigacion Médica Aplicada (FIMA), Pamplona, Spain
Department of Hematology, Mayo Clinic, Phoenix/Scottsdale, AZ, USA
Department of Hematology, Hospital Universitario de Canarias, Tenerife, Spain
Department of Hematology, Hospital Clínico Universitario San Carlos, Madrid, Spain
Department of Hematology, Hospital Clínic of Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Spain
Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain
Department of Hematology, Hospital Clínic of Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Spain
Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain
Department of Hematology, Hospital Universitario Donostia, San Sebastián, Spain
Department of Hematology, Hospital Madrid Norte Sanchinarro, Madrid, Spain
Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain
Department of Hematology, Hospital Sont Llatzer, Palma de Mallorca, Spain
Department of Hematology, Hospital Universitario Vall de Hebrón de Barcelona, Spain
Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain
Department of Hematology, Hospital Clinic i Provincial, Institut d’Investigasions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain
Department of Internal Medicine II, University Hospital Würzburg, Germany
Department of Hematology, Mayo Clinic, Phoenix/Scottsdale, AZ, USA
Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain
Department of Hematology, Fundación de Investigacion Médica Aplicada (FIMA), Pamplona, Spain
Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain
Vol. 103 No. 11 (2018): November, 2018 https://doi.org/10.3324/haematol.2018.188839